Acute Leukemia
description
Transcript of Acute Leukemia
![Page 1: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/1.jpg)
Acute Leukemia
Treatment
![Page 2: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/2.jpg)
PREPARATION
1- Acute leukemia should be regarded as an emergency & needs treatment within 48h of Dx
2- Patient should be prepared for treatment to avoid complications
3- Stabilization of patient & ttt of complications4- Taking consent of patient or family
![Page 3: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/3.jpg)
Preparation--steps
1) Adequate hydration i,v fluids 2-3 L/d of glucose water or normal saline
2) Allopurinol 100-200 mg tds to prevent hyperuricemia
3)Correct anemia- Blood Transfusion 4)Psychological preparation of the patient &
family for ttt & complications5) Tell them about the seriousness of disease &
prognosis
![Page 4: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/4.jpg)
Treatment of Complications
Sometimes the patient presents with complications1- Hemorrhage should be stopped – correct
thrombocytopenia by platelet transfusion. Correct hypovolemia.
2- Fever is regarded due to infection. Never regarded due to leukemic process.
Infection due to neutropenia. Usually due to G-ve bacilli such as Klebsiella, Escherichia, Pseudomomnas, Proteus .
Treated after taking samples for C&S don’t wait the results. Give emperically a 3rd generation cephalosporin (Ceftriaxone)+ gentamicin
![Page 5: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/5.jpg)
Persistent fever
Correct antibiotic according to C&SIf feveer persist think of coagulase –ve Staph &
give VancomycinIf fever persisted think of fungal infection & give
amphotericin-B injectionsIf persisted think of viral infections & treat
accordingly
![Page 6: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/6.jpg)
3- DIC
Mostly seen in APL (M3)Give fresh frozen plasma (FFP), Platewlet
concentrate, blood transfusion4- Hyperuricemic nephropathy – it is prevented
better than treated. It causes renal failure treated by dialysis.
![Page 7: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/7.jpg)
5- Tumor lysis syndrome
Manifested as hyperkalemia, hyperuricemia, hyperphosphatemia, hypocalcemia
It is prevented by preparation & adequate hydration
![Page 8: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/8.jpg)
6- Leukostasis
In AML>ALLEspecially with hyperleukocytosis > 50000 Manifested as CNS & Pulmonary manifestationDue to sludging of blasts in microcirculationCNS- confusion, cranial nerve palsies, seizure, , meningitis, comaPulm- tachypnea, dyspnea, pulmonary crackles, bilateral
radiological pulmonary infiltrates, hypoxemiattt – hydroxyurea, cranial irradition
![Page 9: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/9.jpg)
TREATMENT
1- COMBINATION CHEMOTHERAPY2- Supportive therapy3- Targeted therapy4- BMT & Stem cell Transplant
![Page 10: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/10.jpg)
ALL treatment
1- Induction CT UKALL or BFM protocol*Anthracyclin (Daunorubicin, Doxorubicin)- antibiotic
cytotoxic given weekly ----i.v infusion /1hS/E myelosuppression pancytopenia dilated cardiomyopathy,
mucositis*Vincristine i.v diluted bolus weekly– antitubulin agentS/E
PNP senory> motor, extravasation causes severe necrosis of skin & subcut tissues
Not myrlosuppressive*PDN 60-100 mg/dContinurd for 5 weekly doses
![Page 11: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/11.jpg)
2- Postinduction CT
1- Consolidation giving same doses as induction2- Intensification giving high dose CTShould use new non-cross resistant agentsGiving L-Asparaginase that depletes blasts from
asparagine essential amino acid ( especially useful in children)
![Page 12: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/12.jpg)
3- CNS prophylaxis
1- Intrathecal Methotrexate or cytosine arabinoside & hydrocrtisone given weekly
2- Cranial irradiation giving 2400 rad to cranium to prevent CNS relapse
3- High dose methotrexate crosses BBB
![Page 13: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/13.jpg)
4- Maintenance treatment
1- 6mercaptopurine tab daily2- methotrexate tab weeklyContinued for 2-3 yearsReinforcement doses given every 3 months
![Page 14: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/14.jpg)
AML
1- Induction “3+7” protocolDaunorubicin or Doxorubicin i.v infusion over 1h
D1-D3Cytosine arabinoside continuous infusion 12
hourly D1-D7Given monthly until CR
![Page 15: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/15.jpg)
2- Postinduction CT
A- Consolidation giving same dosesB- Intensification High dose CT *No maintenance ttt in AML except M3* No CNS prophylaxis except M4,M5
![Page 16: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/16.jpg)
Targeted therapy
1- Imatinib in Ph +ve ALL2- All-trans-retinoic acid (ATRA) a differentiating
agent used in M3 induction & maintenanceS/E retinoic acid syndrome3- Gemtuzumab/ozagamycin moAb M3* Arsenic trioxide in M3 relapse
![Page 17: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/17.jpg)
Supportive therapy
1- Stimulating factors (G-CSF, GM-CSF) to correct neutropenia in myelosuppression
2- Plat conc keep plat > 20000/µl3- packed RBCs to correct anemia
![Page 18: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/18.jpg)
BMT
1- syngeneic from identical twin2- Autologous from pt during CR (high risk of
relapse, less GVHD)3- Allogeneic from HLA-matched related or un
related donor ( less relapse, Gvleukemia effect, moreGVHD)
![Page 19: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/19.jpg)
Indications
AML – in 2nd CR after 1st relapseALL- in 3rd CR after 2nd relapse
![Page 20: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/20.jpg)
Prognosis
ALL better AMLALL L1 better than L2 better than L3 Children better than adults (2-9y) female better than male T cell worse than B cell worse than PrepreBAML M3 worse in acute stage but better longterm M4 M5 bad M4E better than M4 M7 bad secondary leuk worse than deNovo
![Page 21: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/21.jpg)
![Page 22: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/22.jpg)
![Page 23: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/23.jpg)
![Page 24: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/24.jpg)
![Page 25: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/25.jpg)
![Page 26: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/26.jpg)
![Page 27: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/27.jpg)
![Page 28: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/28.jpg)
![Page 29: Acute Leukemia](https://reader036.fdocuments.in/reader036/viewer/2022062305/568151a2550346895dbfd239/html5/thumbnails/29.jpg)
Acute Leukemia
Treatment